Summary of all the Indicators
Overall Consensus
Buy
10Bullish
3Neutral
6Bearish
Technical Analysis Consensus
Sell
2Bullish
1Neutral
4Bearish
Moving Average Consensus
Buy
8Bullish
2Neutral
2Bearish
Travere Therapeutics’s (17R) Moving Averages Convergence Divergence (MACD) indicator is <0.01, suggesting Travere Therapeutics is a Buy.
Travere Therapeutics’s (17R) 20-Day exponential moving average is 33.00, while Travere Therapeutics’s (17R) share price is €33, making it a Buy.
Travere Therapeutics’s (17R) 50-Day exponential moving average is 32.99, while Travere Therapeutics’s (17R) share price is €33, making it a Buy.
Travere Therapeutics (17R) Pivot Points
Classic
32.67
32.73
32.87
32.93
33.07
33.13
33.27
Fibonacci
32.73
32.81
32.86
32.93
33.01
33.06
33.13
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.
Travere Therapeutics (17R) Moving Averages
MA5
33.00Sell
33.00Buy
MA10
33.00Neutral
33.00Buy
MA20
33.00Buy
33.00Buy
MA50
33.00Neutral
32.99Buy
MA100
33.00Sell
32.54Buy
MA200
32.01Buy
30.12Buy
Travere Therapeutics’s (17R) 10-Day exponential moving average is 33.00, while Travere Therapeutics’s (17R) share price is €33, making it a Buy.
Travere Therapeutics’s (17R) 100-Day exponential moving average is 32.54, while Travere Therapeutics’s (17R) share price is €33, making it a Buy.
Travere Therapeutics’s (17R) stock price is €33 and Travere Therapeutics’s (17R) 50-day simple moving average is 33.00, creating a Neutral signal.
Travere Therapeutics’s (17R) stock price is €33 and Travere Therapeutics’s (17R) 100-day simple moving average is 33.00, creating a Sell signal.
Travere Therapeutics’s (17R) stock price is €33 and Travere Therapeutics’s (17R) 200-day simple moving average is 32.01, creating a Buy signal.
Travere Therapeutics (17R) Technical Indicators
RSI (14)
65.55
Neutral
STOCH (9,6)
100.00
Sell
STOCHRSI (14)
100.00
Sell
MACD (12,26)
<0.01
Buy
ADX (14)
62.83
Sell
ATR (14)
0.20
-
Ultimate Oscillator
100.00
Buy
Bull/Bear Power (13)
-0.20
Sell
Travere Therapeutics’s (17R) Relative Strength Index (RSI) is 65.55, creating a Neutral signal.
Travere Therapeutics’s (17R) Trend Strength Indicator (ADX) is 62.83, creating a Sell signal.
FAQ
Is 17R a Buy, Hold, or Sell?
Based on 17R’s technical indicators, 17R is a Buy.
What is 17R’s RSI (14)?
17R’s RSI (14) is 65.55, which suggests 17R is a Neutral.
What is 17R’s MACD?
17R’s MACD is <0.01, which suggests 17R is a Buy.
What is 17R’s 5-day moving average?
17R’s 5-day moving average is 33.00, which suggests 17R is a Sell.
What is 17R’s 20-day moving average?
17R 20-day moving average is 33.00, which suggests 17R is a Buy.
What is 17R’s 50-day moving average?
17R’s 50-day moving average is 33.00, which suggests 17R is a Neutral.
What is 17R’s 200-day moving average?
17R’s 200-day moving average is 32.01, which suggests 17R is a Buy.
What is 17R’s Williams % R (14)?
17R’s Williams % R (14) is 0.00, which suggests 17R is a Buy.
What is 17R’s CCI (14)?
17R’s CCI (14) is 0.00, which suggests 17R is a Neutral.
What is the share price of Travere Therapeutics?
Travere Therapeutics's share price is N/A€.